(Q40708672)

23 September 2017

1 reference

title

Pitfalls and problems of the long term use of neuroleptic drugs in schizophrenia (English)

1 reference

23 September 2017

1 reference

M F Bristow

1

1 reference

23 September 2017

S R Hirsch

series ordinal

2

1 reference

23 September 2017

1 February 1993

1 reference

23 September 2017

1 reference

23 September 2017

8

1 reference

23 September 2017

136-148

1 reference

23 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-199308020-00004

23 September 2017

0 references

cites work

Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses

1 reference

12 December 2020

Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial. Report to the Medical Research Council Committee on Clinical Trials in Psychiatry.

1 reference

12 December 2020

Cognitive impairment, clinical course and treatment history in out-patients with bipolar affective disorder: relationship to tardive dyskinesia

1 reference

12 December 2020

Prospective study of tardive dyskinesia in the elderly

1 reference

12 December 2020

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

12 December 2020

Seizure activity associated with antipsychotic therapy

1 reference

12 December 2020

The association between the neuroleptic malignant syndrome and malignant hyperthermia.

1 reference

12 December 2020

Trihexyphenidyl abuse: therapeutic implications for negative symptoms of schizophrenia?

1 reference

12 December 2020

Depression 'revealed' in schizophrenia

1 reference

12 December 2020

Neuroleptic withdrawal in patients meeting criteria for supersensitivity psychosis

1 reference

12 December 2020

A prospective analysis of 24 episodes of neuroleptic malignant syndrome

1 reference

12 December 2020

Adjunctive imipramine in the treatment of postpsychotic depression. A controlled trial

1 reference

12 December 2020

Risk factors for neuroleptic malignant syndrome. A case-control study

1 reference

12 December 2020

Depressive symptoms in chronic schizophrenic patients after withdrawal of long-acting neuroleptics

1 reference

12 December 2020

Neuroleptic malignant syndrome: review and analysis of 115 cases

1 reference

12 December 2020

HLA-B38, DR4, DQw3 and clozapine-induced agranulocytosis in Jewish patients with schizophrenia

1 reference

12 December 2020

PHENOTHIAZINE TREATMENT IN ACUTE SCHIZOPHRENIA; EFFECTIVENESS: THE NATIONAL INSTITUTE OF MENTAL HEALTH PSYCHOPHARMACOLOGY SERVICE CENTER COLLABORATIVE STUDY GROUP

1 reference

12 December 2020

Seizures with neuroleptics and antidepressants

1 reference

12 December 2020

The abrupt withdrawal of antiparkinsonian drugs in schizophrenic patients

1 reference

12 December 2020

Neuroleptic malignant syndrome in 12 of 9,792 Chinese inpatients exposed to neuroleptics: a prospective study

1 reference

12 December 2020

Neuroleptic-induced akathisia: a review

1 reference

12 December 2020

An evaluation of papaverine in tardive dyskinesia

1 reference

12 December 2020

Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics

1 reference

12 December 2020

Clinical characteristics of akathisia. A systematic investigation of acute psychiatric inpatient admissions.

1 reference

12 December 2020

Monitoring plasma concentrations of neuroleptics

1 reference

12 December 2020

Natural history and treatment of tardive dystonia.

1 reference

12 December 2020

Clozapine effects on tardive dyskinesia

1 reference

12 December 2020

Acute laryngeal dystonic reactions to neuroleptics

1 reference

12 December 2020

Dystonia--a potential psychiatric pitfall

1 reference

12 December 2020

Clonazepam and phenobarbital in tardive dyskinesia

1 reference

12 December 2020

Serial plasma prolactin levels in neuroleptic-induced galactorrhea: a case report

1 reference

12 December 2020

Drug-induced dystonia in young and elderly patients

1 reference

12 December 2020

Abnormal involuntary movements and chronic schizophrenic disorders.

1 reference

12 December 2020

Psychotropic medication and priapism: a comprehensive review

1 reference

12 December 2020

Prediction of neuroleptic-induced dystonia

1 reference

12 December 2020

Increased saccadic distractibility in tardive dyskinesia: functional evidence for subcortical GABA dysfunction

1 reference

12 December 2020

Tardive dystonia: clinical aspects and treatment

1 reference

12 December 2020

A comparison of severe tardive dystonia and severe tardive dyskinesia

1 reference

12 December 2020

Sensitivity to chlorpromazine effects on brain function of schizophrenics and normals. A preliminary report.

1 reference

12 December 2020

Sub-syndromes of tardive dyskinesia.

1 reference

12 December 2020

Use of Antidepressant Drugs in Schizophrenia

1 reference

12 December 2020

Striatal dopamine D2 receptors in tardive dyskinesia: PET study

1 reference

12 December 2020

Heterogeneity of tardive dyskinesia. A multivariate analysis.

1 reference

12 December 2020

Neuropsychiatry of prolactin: causes and effects

1 reference

12 December 2020

Studies of depressive symptoms in schizophrenia

1 reference

12 December 2020

1 reference

12 December 2020

The importance of dosage in antipsychotic drug administration--a review of dose-response studies

1 reference

12 December 2020

Antipsychotic withdrawal symptoms: phenomenology and pathophysiology

1 reference

12 December 2020

Sexual side effects of antipsychotic medication: evaluation and interventions

1 reference

12 December 2020

A clinical trial of the efficacy and acceptability of D-fenfluramine in the treatment of neuroleptic-induced obesity.

1 reference

12 December 2020

Negative symptoms, tardive dyskinesia and depression in chronic schizophrenia

1 reference

12 December 2020

Comparative Doses and Costs of Antipsychotic Medication

1 reference

12 December 2020

Efficacy of anticholinergic prophylaxis for neuroleptic-induced acute dystonia

1 reference

12 December 2020

Idiopathic Parkinson's disease in a chronic schizophrenic patient: long-term treatment with clozapine and L-dopa

1 reference

12 December 2020

Therapeutic antagonism between anticholinergic antiparkinsonism agents and neuroleptics in schizophrenia. Implications for a neuropharmacological model

1 reference

12 December 2020

Effect of anticholinergics on tardive dyskinesia. A controlled discontinuation study

1 reference

12 December 2020

Bone density and reproductive hormones in patients with neuroleptic-induced hyperprolactinemia

1 reference

12 December 2020

The prevalence of tardive dyskinesia in neuroleptic-treated diabetics. A controlled study.

1 reference

12 December 2020

The effect of long-term treatment with clozapine in schizophrenia: a retrospective study in 96 patients treated with clozapine for up to 13 years

1 reference

12 December 2020

Neuroleptic malignant syndrome. Review of response to therapy

1 reference

12 December 2020

10.2165/00002018-199308020-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

23 September 2017

1032814139

0 references

Fatcat ID

release_wjvbln7a5zha7ja3e7xd3p2bpy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wjvbln7a5zha7ja3e7xd3p2bpy

24 November 2022

mapped directly with Wikidata item

1 reference